Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.352 5-Year IF: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v21.i5.10
28 pages

Macrophage Arginine Metabolism to Ornithine/Urea or Nitric Oxide/Citrulline: A Life or Death Issue

Charles D. Mills
Department of Surgery and Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota Hospitals and Clinics, Box 120, 420 Delaware St. SE, Minneapolis, MN 55455

ABSTRACT

Macrophages can metabolize arginine to nitric oxide in quantities that inhibit pathogens or nearby host cells. They can instead metabolize arginine to ornithine (a precursor of polyamines and collagen) in quantities that stimulate pathogens or nearby host cells. Macrophages are essentially the only circulating cells that can make these life or death decisions with arginine. Macrophages expressing these destructive or constructive phenotypes have been termed M-1 or M-2 because they also stimulate TH1 or TH2 responses, respectively. Factors that influence whether a macrophage expresses the M-1 or M-2 phenotype and the real or potential impact on immune responses and other host processes are discussed.


Articles with similar content:

Macrophage Polarization: Implications on Metabolic Diseases and the Role of Exercise
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 2
Loreana Sanches Silveira, Barbara de Moura Mello Antunes, José Cesar Rosa Neto, Ronaldo Vagner Thomatieli dos Santos, Fábio Santos Lira, Andre Luis Araujo Minari
The Receptor for β-Glucan of Ganoderma lucidum (W.Curt.:Fr.) Lloyd in Immune Cells
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Ha Won Kim, Byong Kak Kim
Manning the Barricades: Lung Fibroblasts and CD4+ T Cells as the Last Line of Defense against Bacterial Invasion?
Critical Reviews™ in Immunology, Vol.38, 2018, issue 5
Jane A. Warner, Andrew J. Hutton, Karl J. Staples
Signal Integration Following Toll-like Receptor Triggering
Critical Reviews™ in Immunology, Vol.22, 2002, issue 3
Alexander Dalpke, Klaus Heeg
A CCL2-Based Fusokine as a Novel Biopharmaceutical for the Treatment of CCR2-Driven Autoimmune Diseases
Critical Reviews™ in Immunology, Vol.30, 2010, issue 5
Jacques Galipeau, Moutih Rafei